CClinicalTrials.gg
Status unknownNCT02164149ColonCTUpdated Jun 16, 2014

Length of Tumour Feeding Artery After Colon Cancer Surgery

An observational study in Colon Cancer, sponsored by University of Aarhus. Status unknown at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2014-06-16.

Sponsored by University of Aarhus · Observational

The sponsor has not verified this record recently (last verified Jun 2014), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
65
Ages
18 Years and older
Sex
All
01

Study summary

The quality of colon cancer surgery is highly debated these years since the mortality of the disease is not declining markedly. Surgery is the main treatment of colon cancer and during surgery it is very important for the surgeon to remove the tumour and all potential ways of tumour spread. As colon cancer first of all spreads to the nearby lymph nodes lying along the tumour feeding artery the surgeon aims to cut the vessel as central as possible. This means that all of the tumour feeding artery should have been removed after surgery.

In this study the investigators want to measure the length of the tumour feeding artery after surgery as a quality control of the surgery. The investigators hypothesize that the artery will be shorter than 5 mm.

The investigators wish to CT scan all patients two days after colon cancer surgery and afterwards measure then length of the artery on the images. This study will not inflict with the normal routine for patient information and treatment.

02

Conditions studied

  • Colon Cancer

Browse trials for

Keywords

  • Colon cancer
  • Quality of surgery
  • Length of tumour feeding artery
03

In context

Colonic Neoplasms

1,432 studies on the registry are indexed under Colonic Neoplasms; 357 are open to participants now.

This study's planned enrollment of 65 is below the median of 280 across 349 observational studies indexed under Colonic Neoplasms.

Browse Colonic Neoplasms studies →

Lead sponsor

University of Aarhus is the lead sponsor of 1,274 studies on the registry; 183 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All patients over 18 years with primary colon cancer, who are to have surgery at Randers Regional Hospital, Denmark.

Inclusion criteria

  • Primary colon cancer

Exclusion criteria

Exclusion Criteria:

  • Kidney failure, allergy to contrast, pregnancy
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
65 participants (estimated)
Patient registry
No

Groups and cohorts

  • Quality of colon cancer surgery

    Patients with primary colon cancer

    Other: Patients with primary colon cancer

Interventions

  • OtherPatients with primary colon cancer

    CT scan two days after surgery

06

What researchers measure

Primary outcomes

  1. CT scan after colon cancer surgery. The length of the tumour feeding artery will be measured on the images.

    Patients will have an extra CT scan two days after surgery.

    Time frame: 6 to 9 months

07

Study locations

1 of 1 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 16, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02164149
Lead sponsor
University of Aarhus
Responsible party
Sponsor
First posted
Jun 16, 2014
Start date
May 2014
Primary completion
Nov 2014 (estimated)
Completion
Nov 2015 (estimated)
Last update
Jun 16, 2014

Study contacts

Ditte Munkedal, MD
Contact
Ditte.Munkedal@viborg.rm.dk
+45 7846 7710
Soren Laurberg, Professor
Contact
soeren.laurberg@aarhus.rm.dk
+45 7846 7715
Soren Laurberg, Professor
study director · Aarhus University Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jun 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion